Myeloma2018
E-learning

Catch up on Myeloma2018 webcasts now!

The Myeloma2018 meeting was held in San Diego, on 7-9 September. The meeting provided an opportunity for leading experts in multiple myeloma (MM) to present and discuss the latest data and advancements in the field.

Treatment regimens for MM have continued to improve in recent years, as a result of extensive research in the field, leading to further developments in novel drug targets, drug combinations and biomarkers, all of which were featured during the Myeloma2018 meeting!
Clinical genetics, measurable residual disease (MRD), immunotherapy and drug resistance were also among the topics thoroughly discussed by the delegates. VJHemOnc are pleased to share exclusive, on-demand webcast presentations from the meeting.

Watch all of our webcasts here to stay up-to-date on current advances in myeloma presented at Myeloma2018.

Session I: Clinical Genomics

Featured speakers:
Suzanne Trudel, MD, FRCPC
Ola Landgren, MD, PhD
Angela Dispenzieri, MD

Session I
Session II: Genomics 2018 – What Have We Learned

Featured speakers:
Yuan Xiao Zhu, PhD

Session II
Session III: Epigenetics

Featured speakers:
Constantine Mitsiades, MD, PhD
Brian Walker, PhD
Felipe Prosper, PhD

Session III
Session IV: Novel Targets

Featured speakers:
Enrique Ocio, MD, PhD
Keith Stewart, MBChB
Robert Orlowski, MD

Session IV
Session V: Progression of MGUS-SMM-MM

Featured speakers:
Celine Vachon, PhD
Elisabet Manasanch, MD
Jose Martinez-Climent, MD

Session V
Session VI: Microenvironment

Featured speakers:
Kyohei Nakamura, MD, PhD
Bruno Paiva, PhD
Marta Chesi, PhD

Session VI:
Session VII: Genomics of Drug Resistance

Featured speakers:
Brian Van Ness, PhD
Anja Seckinger, MD
Arun Wiita, MD, PhD

Session VII
Session VIII: Immunotherapy of Myeloma – T Cell Engagement

Featured speakers:
Adam Cohen, MD
Yi Lin, MD, PhD
Krina Patel, MD

Session VIII